Hill Dickinson’s London Corporate team has recently advised Turner Pope Investments in connection with the admission of Graft Polymer (UK) plc to trading on the standard list of the main market of the London Stock Exchange together with a £5 million fundraise.
Established in 2017 by a group of polymer technology experts and venture capitalists, Graft Polymer’s core business comprises polymer modification and development of drug delivery systems.
The group is a highly innovative business with strong intellectual property, holding several patent applications. The fundraising of £5 million is to fund accelerated growth, expand the group’s research and production facility in Slovenia to meet rising customer demand, upgrade existing facilities to enable future IP registration, and increase both inventory and marketing opportunities following expected increased sales.
Graft Polymer’s shares were admitted to trading on 6 January 2022, with the ticker ‘LSE:GPL’ and a market capitalisation on admission of £22.4 million. The listing is the first on the main market of the London Stock Exchange in 2022.
Hill Dickinson legal director Sam Hudson and partner James Paton-Philip led on the transaction, with support from trainee solicitor Amelia Chung and paralegals Mariam El-Mir and Oliver Hart.
We are delighted to have been able to assist Turner Pope Investments in connection with this transaction. We wish them, and Graft Polymer, the best of luck for 2022 and beyond.Sam Hudson
Legal Director
Sam Hudson commented: “We are delighted to have been able to assist Turner Pope Investments in connection with this transaction. We wish them, and Graft Polymer, the best of luck for 2022 and beyond.”
Further information on Graft Polymer can be found on the company’s website www.graftpolymer.com.